How I prevent... smouldering acne;Comment je préviens... par des soins dermo-cosmétiques, l'expression d'une acné qui couve

Revue Medicale de Liege

Volumn 60, Issue 9, 2005, Pages 741-743

  Pierard G E ^a   Pierard Franchimont C ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

Acne; Defensin; Dermo cosmetology; Toll like receptor

Indexed keywords

ACNE; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; ESTHETIC SURGERY; HUMAN; PATHOGENESIS; SKIN DEFECT;

ACNE VULGARIS; HUMANS;

EID: 26444594309     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Beylot C.-Mécanismes et causes de l'acné. Rev Prat, 2002, 52, 828-830.
2. Piérard GE, Piérard-Franchimont C, Lê T.-Seborrhoea in acne-prone and acne-free patients. Dermatologica, 1987, 175, 5-9.
3. Piérard GE, Piérard-Franchimont C, Lê T, Lapière ChM.-Patterns of follicular sebum excretion rate during lifetime. Arch Dermatol Res, 1987, 279, S104-S107.
4. Piêrard-Franchimont C, Piêrard GE, Saint Lêger D, et al.-Comparison of the kinetics of sebum secretion in young women with and without acne. Dermatologica, 1991, 183, 120-122.
5. Rock FL, Hardiman G, Timans JC, et al.-A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA, 1998, 95, 588-593.
6. Underhill DM, Ozinsky A, Smith KD, Aderem A.-Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA, 1999, 96, 14459-14463.
7. Takeuchi O, Hoshino K, Kawai T, et al.-Differential roles of TLR-2 and TLR-4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity, 1999, 1, 443-451.
8. Hoshino K, Takeuchi O, Kawai T, et al.-Cutting edge : Toll-like receptor 4 (TLR-4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR-4 as the Lps gene product. J Immunol, 1999, 162, 3749-3752.
9. Aderem A, Ulevitch RJ.-Toll-like receptors in the induction of the innate immune response. Nature, 2000, 406, 782-787.
10. Kim J, Ochao MT, Krutzik SR, et al.-Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol, 2002, 169, 1535-1541.
11. Medzhitov R, Janeway C.-Innate immunity. N Engl J Med, 2000, 343, 338-344.
12. Janeway CAJ, Medzhitov R.-Innate immune recognition. Am Rev Immunol, 2002, 20, 197-216.
13. Philpott M.-Defensins and acne. Molec Immunol, 2003, 40, 457-462.
14. Weiss JS.-Current options for the topical treatment of acne vulgaris. Pediatr Dermatol, 1997, 14, 480-488.
15. Russell JJ.-Topical therapy for acne. Am Fam Physician, 2000, 61, 357-366.
16. Uhoda E, Piérard-Franchimont C, Piérard GE.-Comedolysis by a lipohydroxyacid formulation in acne prone subjects. Eur J Dermatol, 2003, 13, 65-68.
17. Piérard GE, Rougier A.-Nudging acne by topical beta-lipohydroxyacid (LHA), a new comedolytic agent. Eur J Dermatol, 2002, 12, S47-S48.
18. Piérard GE, Piérard-Franchimont C.-Effect of a topical erythromycin-zinc formulation on sebum delivery. Evaluation by a combined photometric-multi-step samplings with Sebutape. Clin Exp Dermatol, 1993, 18, 410-413.
19. Letawe C, Boone M, Piérard GE.-Digital image analysis of the effect of topically applied linoleic acid on acne microcomedones. Clin Exp Dermatol, 1998, 23, 56-58.
20. Piérard-Franchimont C, Goffin V, Visser JN, et al.-A double-blind controlled evaluation of the sebosuppressive activity of topical erythromycin-zinc complex. Eur J Clin Pharmacol, 1995, 49, 57-60.
21. Piérard GE, Cauwenbergh G.-Modulation of sebum excretion from the follicular reservoir by a dichlorophenyl-imidazoldioxolan. Int J Cosmet Sci, 1996, 18, 219-228.
22. Piérard GE, Ries G, Cauwenbergh G.-New insight in the topical management of excessive sebum flow at the skin surface. Dermatology, 1998, 196, 126-129.
23. Piérard-Franchimont C, Martalo O, Richard A, et al.-Sebum rheology evaluated by two methods in vivo. Split-face study of the effect of a cosmetic formulation. Eur J Dermatol, 1999, 9, 455-457.